share_log

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

twist bioscience發佈了樂觀的業績,加入了特斯拉、Amylyx製藥、regenxbio和其他大股票在週一上漲。
Benzinga ·  11/18 22:59

U.S. stocks were mixed, with the Dow Jones index falling around 80 points on Monday.

美國股市表現不一,道瓊斯指數週一下跌約80點。

Shares of Twist Bioscience Corporation (NASDAQ:TWST) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter EPS and sales.

特朗普概念公司股份(納斯達克:twst)在週一交易中大幅上漲,此前公司報告顯示第四季度每股收益和銷售額均超過預期。

Twist Bioscience reported a quarterly loss of 59 cents per share which beat the analyst consensus estimate of a loss of 70 cents per share. The company reported quarterly sales of $84.71 million which beat the analyst consensus estimate of $82.20 million.

twist bioscience公司報告第四季度每股虧損59美分,超過分析師共識預估的每股虧損70美分。該公司報告第四季度銷售額爲8471萬美元,超過分析師共識預估的8220萬美元。

Twist Bioscience shares jumped 10.7% to $40.86 on Monday.

週一,twist bioscience股價上漲10.7% 至40.86美元。

Here are some other big stocks recording gains in today's session.

以下是今天交易中漲幅較大的其他大股票。

  • WeRide Inc. (NASDAQ:WRD) shares gained 19% to $20.67.
  • Super Micro Computer, Inc. (NASDAQ:SMCI) shares surged 19% to $22.12. This surge comes as the company faces potential delisting from the Nasdaq Stock Market.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) shares climbed 17% to $5.56 after Baird upgraded the stock from Neutral to Outperform and raised its price target from $3 to $11.
  • REGENXBIO Inc. (NASDAQ:RGNX) shares climbed 17% to $11.30 after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
  • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 16.2% to $37.41.
  • Semler Scientific, Inc. (NASDAQ:SMLR) shares rose 14.6% to $51.00. Semler Scientific announced it acquired 215 bitcoins for $17.7 million in cash, at an average price of $82,502 per bitcoin, inclusive of fees and expenses, during the period between Nov. 6 and Nov. 15.
  • Red Cat Holdings, Inc. (NASDAQ:RCAT) rose 14% to $5.36.
  • REGENXBIO Inc. (NASDAQ:RGNX) gained 13.2% to $10.90 after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
  • Mobileye Global Inc. (NASDAQ:MBLY) rose 8.1% to $16.20.
  • Zeta Global Holdings Corp. (NYSE:ZETA) shares rose 7.4% to $18.90. Zeta Global said David A. Steinberg, Zeta's Co-Founder, Chairman and CEO, members of the Company's leadership, and members of the Board of Directors intend to purchase shares of Zeta's Class A common stock on Monday.
  • Aurora Innovation, Inc. (NASDAQ:AUR) gained 7.2% to $5.35.
  • IAMGOLD Corporation (NYSE:IAG) rose 6.8% to $5.28.
  • Tesla, Inc. (NASDAQ:TSLA) shares gained 6.1% to $340.21 following reports of President-elect Donald Trump's policy outlook on regulations for autonomous driving.
  • NIO Inc. (NYSE:NIO) rose 4% to $4.6650.
  • 蔚來汽車公司(納斯達克:wrd)股價上漲19% 至20.67美元。
  • 超微計算機公司(納斯達克:smci)股價暴漲19% 至22.12美元。此次飆升是因爲該公司面臨納斯達克股票市場潛在除牌。
  • Amylyx製藥公司(納斯達克:amlx)股價上漲17% 至5.56美元,這是在貝爾德將股票評級從中立提升至表現優異,並將其價格目標從3美元提高至11美元后的表現。
  • REGENXBIO公司(納斯達克股票代碼:RGNX)股價上漲17%,達到11.30美元,因該公司宣佈對杜歐肌營養不良基因治療的關鍵試驗首例患者進行了服藥。
  • Destiny Tech100公司(納斯達克股票代碼:DXYZ)股價上漲16.2%,達到37.41美元。
  • Semler Scientific, Inc.(納斯達克股票代碼:SMLR)股價上漲14.6%,達到51.00美元。Semler Scientific宣佈以1770萬美元現金收購215個比特幣,平均價格爲每個比特幣82502美元,包括費用和開支,交易時間爲11月6日至11月15日之間。
  • Red Cat Holdings, Inc.(納斯達克股票代碼:RCAT)上漲14%,達到5.36美元。
  • REGENXBIO公司(納斯達克股票代碼:RGNX)上漲13.2%,達到10.90美元,因該公司宣佈對杜歐肌營養不良基因治療的關鍵試驗首例患者進行了服藥。
  • Mobileye Global Inc.(納斯達克股票代碼:MBLY)上漲8.1%,達到16.20美元。
  • Zeta Global Holdings Corp.(紐約證券交易所股票代碼:ZETA)股價上漲7.4%,達到18.90美元。Zeta Global表示,公司聯合創始人、董事長兼首席執行官David A. Steinberg、公司領導層成員以及董事會成員打算在週一購買Zeta的A類普通股。
  • Aurora Innovation, Inc.(納斯達克股票代碼:AUR)上漲7.2%,達到5.35美元。
  • iamgold股份有限公司 (NYSE:IAG) 上漲6.8%,至5.28美元。
  • 特斯拉公司 (NASDAQ:TSLA) 股價上漲6.1%,達340.21美元,據報道,候任總統特朗普對自動駕駛監管政策的展望。
  • NIO公司 (NYSE:NIO) 上漲4%,至4.6650美元。

Now Read This:

現在閱讀這個:

  • Jim Cramer: Super Group Finally 'Broke Out,' This Basic Materials Stock Is 'Very Hard To Own Here'
  • 吉姆·克萊默:Super Group終於『衝破』,這家基礎材料股票『在這裏非常難以擁有』

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論